Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.

Genetics in medicine : official journal of the American College of Medical Genetics - 1 May 2011

Christensen Kurt D, Roberts J Scott, Uhlmann Wendy R, Green Robert C

Abstract excerpt

PURPOSE: Perceptions about the pros and cons of genetic susceptibility testing are among the best predictors of test utilization. How actual testing changes such perceptions has yet to be examined. METHODS: In a clinical trial, first-degree relatives of patients with Alzheimer disease received genetic risk assessments for Alzheimer disease including APOE disclosure. Participants rated 11 possible benefits...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Aged, 80 and over

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Alzheimer Disease

Share to Apolipoproteins E

Share to Genetic Testing

Share to Molecular Typing

Share to Perception

Share to Risk Assessment

Source

Open in PubMed Open full text

Identifiers

PMID: 21270636
DOI: 10.1097/GIM.0b013e3182076bf1
PMCID: PMC3170997

Genes

APOE

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Changes to perceptions of the pros and cons of genetic susceptibility testing after APOE genotyping for Alzheimer disease risk.PMID 21270636Read ↗

Using Alzheimer's disease as a model for genetic risk disclosure: implications for personal genomics.Semantic proximity Read ↗

The role of disease perceptions and results sharing in psychological adaptation after genetic susceptibility testing: the REVEAL Study.Semantic proximity Read ↗

Disclosure of APOE genotype for risk of Alzheimer's disease.Semantic proximity Read ↗

Disclosing Genetic Risk of Alzheimer's Disease to Cognitively Unimpaired Older Adults: Findings from the Study of Knowledge and Reactions to APOE Testing (SOKRATES II).Semantic proximity Read ↗

Genetic susceptibility testing versus family history-based risk assessment: Impact on perceived risk of Alzheimer disease.Semantic proximity Read ↗

Predictive genetic testing for Alzheimer's disease: impact upon risk perception.Semantic proximity Read ↗

Assessing the Psychological Impact of Genetic Susceptibility TestingSemantic proximity Read ↗

Genetic risk assessment for adult children of people with Alzheimer's disease: the Risk Evaluation and Education for Alzheimer's Disease (REVEAL) study.Semantic proximity Read ↗

"Well, good luck with that": reactions to learning of increased genetic risk for Alzheimer disease.Semantic proximity Read ↗

To know or not to know: an update of the literature on the psychological and behavioral impact of genetic testing for Alzheimer disease risk.Semantic proximity Read ↗

Health behavior changes after genetic risk assessment for Alzheimer disease: The REVEAL Study.Semantic proximity Read ↗

Perceptions of familial risk in those seeking a genetic risk assessment for Alzheimer's disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.